Skip to main content
HHS
NASDAQ Trade & Services

Harte Hanks to Be Acquired by Star Equity for $5.00/Share in Cash or Preferred Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Positive
Importance info
9
Price
$4.22
Mkt Cap
$31.904M
52W Low
$2
52W High
$4.5
52W Position info
111% above low
Off High info
6.2% below high
Rel. Volume info
58× avg
Market data snapshot near publication time

HHS has more than doubled off its 52-week low of $2 on elevated volume (58× avg).

Summary

Harte Hanks agreed to be acquired by Star Equity Holdings for $5.00 per share in cash or preferred stock, a deal valued at approximately $38.4 million, expected to close in Q4 2026.


Key Events · M&A and Partnerships · HHS

  • Definitive Merger Agreement Signed

    A merger agreement with Star Equity Holdings was signed on August 14, 2026. Each share of Harte Hanks common stock will be converted into the right to receive either $5.00 in cash or 0.50 shares of Star Equity preferred stock, subject to a 50% cap on aggregate cash consideration.

  • Total Consideration Valued at ~$38.4M

    The parties estimate total consideration of approximately 1.92 million shares of Star Equity preferred stock and $19.2 million in cash. At the implied $10.00 per preferred share value, the total deal value is approximately $38.4 million.

  • Financing Structure

    Star Equity intends to finance the cash component partly by drawing up to $15 million on its existing revolving credit facility, with the balance from cash on hand.

  • Closing Expected in Q4 2026

    The transaction is subject to Harte Hanks stockholder approval and other customary conditions. Closing is expected in the fourth quarter of 2026.


Analysis · HHS · Trade & Services

A definitive merger agreement with Star Equity Holdings was signed on August 14, 2026, setting the stage for a transformative liquidity event. Shareholders will receive either $5.00 per share in cash or 0.50 shares of Star Equity preferred stock, subject to a 50% cap on aggregate cash consideration. The total deal value is approximately $38.4 million (1.92 million preferred shares at $10.00 implied value plus $19.2 million cash). The transaction is expected to close in Q4 2026, pending stockholder approval and other conditions. This provides liquidity to shareholders at a premium to the current stock price of $4.22.

At the time of this filing, HHS was trading at $4.22 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $31.9M. The 52-week trading range was $2.00 to $4.50. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HHS - Latest Insights

HHS
May 15, 2026, 8:16 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $4.24 info
Change: +$1.43 (+51%) info
Market Cap: $31.904M info
HHS
May 14, 2026, 4:24 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $4.24 info
Change: +$1.43 (+51%) info
Market Cap: $31.904M info
HHS
Mar 17, 2026, 5:20 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $2.67
Real-time Price: $4.24 info
Change: +$1.57 (+59%) info
Market Cap: $31.904M info